These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20097401)

  • 1. SIVagm containing the SHIV89.6P Envelope gene replicates poorly and is non-pathogenic.
    Perković M; Norley S; Sanzenbacher R; Battenberg M; Panitz S; Coulibaly C; Flory E; Siegismund C; Münk C; Cichutek K
    Virology; 2010 Mar; 399(1):87-97. PubMed ID: 20097401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIVagm: genetic and biological features associated with replication.
    Müller MC; Barré-Sinoussi F
    Front Biosci; 2003 Sep; 8():d1170-85. PubMed ID: 12957815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease.
    Broussard SR; Staprans SI; White R; Whitehead EM; Feinberg MB; Allan JS
    J Virol; 2001 Mar; 75(5):2262-75. PubMed ID: 11160730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of viral replication during primary simian immunodeficiency virus SIVagm infection are rapidly and strongly controlled in African green monkeys.
    Diop OM; Gueye A; Dias-Tavares M; Kornfeld C; Faye A; Ave P; Huerre M; Corbet S; Barre-Sinoussi F; Müller-Trutwin MC
    J Virol; 2000 Aug; 74(16):7538-47. PubMed ID: 10906207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DC-SIGN from African green monkeys is expressed in lymph nodes and mediates infection in trans of simian immunodeficiency virus SIVagm.
    Ploquin MJ; Diop OM; Sol-Foulon N; Mortara L; Faye A; Soares MA; Nerrienet E; Le Grand R; Van Kooyk Y; Amara A; Schwartz O; Barré-Sinoussi F; Müller-Trutwin MC
    J Virol; 2004 Jan; 78(2):798-810. PubMed ID: 14694112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simian Immunodeficiency Virus SIVagm Efficiently Utilizes Non-CCR5 Entry Pathways in African Green Monkey Lymphocytes: Potential Role for GPR15 and CXCR6 as Viral Coreceptors.
    Riddick NE; Wu F; Matsuda K; Whitted S; Ourmanov I; Goldstein S; Goeken RM; Plishka RJ; Buckler-White A; Brenchley JM; Hirsch VM
    J Virol; 2015 Dec; 90(5):2316-31. PubMed ID: 26656714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusion of the upstream vpu sequences to the env of simian human immunodeficiency virus (SHIV(KU-1bMC33)) results in the synthesis of two envelope precursor proteins, increased numbers of virus particles associated with the cell surface and is pathogenic for pig-tailed macaques.
    Hout DR; Gomez ML; Pacyniak E; Mulcahy ER; Gomez LM; Jackson M; Flick M; Fegley B; McCormick C; Wisdom BJ; Culley N; Pinson DM; Powers M; Wong SW; Stephens EB
    Virology; 2004 May; 323(1):91-107. PubMed ID: 15165822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronology of genetic changes in the vpu, env, and Nef genes of chimeric simian-human immunodeficiency virus (strain HXB2) during acquisition of virulence for pig-tailed macaques.
    McCormick-Davis C; Zhao LJ; Mukherjee S; Leung K; Sheffer D; Joag SV; Narayan O; Stephens EB
    Virology; 1998 Sep; 248(2):275-83. PubMed ID: 9721236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal immunopathogenesis by SIV/HIV-1 (SHIV) containing a variant form of the HIV-1SF33 env gene in juvenile and newborn rhesus macaques.
    Luciw PA; Mandell CP; Himathongkham S; Li J; Low TA; Schmidt KA; Shaw KE; Cheng-Mayer C
    Virology; 1999 Oct; 263(1):112-27. PubMed ID: 10544087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plateau levels of viremia correlate with the degree of CD4+-T-cell loss in simian immunodeficiency virus SIVagm-infected pigtailed macaques: variable pathogenicity of natural SIVagm isolates.
    Goldstein S; Ourmanov I; Brown CR; Plishka R; Buckler-White A; Byrum R; Hirsch VM
    J Virol; 2005 Apr; 79(8):5153-62. PubMed ID: 15795299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral outcome of simian-human immunodeficiency virus SHIV-89.6P adapted to cynomolgus monkeys.
    Borsetti A; Baroncelli S; Maggiorella MT; Bellino S; Moretti S; Sernicola L; Belli R; Ridolfi B; Farcomeni S; Negri DR; Cafaro A; Ensoli B; Titti F
    Arch Virol; 2008; 153(3):463-72. PubMed ID: 18080858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8+ T lymphocytes of African green monkeys secrete an immunodeficiency virus-suppressing lymphokine.
    Ennen J; Findeklee H; Dittmar MT; Norley S; Ernst M; Kurth R
    Proc Natl Acad Sci U S A; 1994 Jul; 91(15):7207-11. PubMed ID: 7913749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection of rhesus macaques with a pool of simian immunodeficiency virus with the envelope genes from acute HIV-1 infections.
    Krebs KC; Tian M; Asmal M; Ling B; Nelson K; Henry K; Gibson R; Li Y; Han W; Shattock RJ; Veazey RS; Letvin N; Arts EJ; Gao Y
    AIDS Res Ther; 2016 Nov; 13(1):41. PubMed ID: 27906032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simian immunodeficiency virus SIVmac239 infection and simian human immunodeficiency virus SHIV89.6P infection result in progression to AIDS in cynomolgus macaques of Asian origin.
    Okamura T; Tsujimura Y; Soma S; Takahashi I; Matsuo K; Yasutomi Y
    J Gen Virol; 2016 Dec; 97(12):3413-3426. PubMed ID: 27902330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral burden and disease progression in rhesus monkeys infected with chimeric simian-human immunodeficiency viruses.
    Reimann KA; Watson A; Dailey PJ; Lin W; Lord CI; Steenbeke TD; Parker RA; Axthelm MK; Karlsson GB
    Virology; 1999 Mar; 256(1):15-21. PubMed ID: 10087222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques.
    Demberg T; Florese RH; Heath MJ; Larsen K; Kalisz I; Kalyanaraman VS; Lee EM; Pal R; Venzon D; Grant R; Patterson LJ; Korioth-Schmitz B; Buzby A; Dombagoda D; Montefiori DC; Letvin NL; Cafaro A; Ensoli B; Robert-Guroff M
    J Virol; 2007 Apr; 81(7):3414-27. PubMed ID: 17229693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simian immunodeficiency virus infection in a patas monkey (Erythrocebus patas): evidence for cross-species transmission from African green monkeys (Cercopithecus aethiops sabaeus) in the wild.
    Bibollet-Ruche F; Galat-Luong A; Cuny G; Sarni-Manchado P; Galat G; Durand JP; Pourrut X; Veas F
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():773-81. PubMed ID: 8627266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simian immunodeficiency virus of African green monkeys is apathogenic in the newborn natural host.
    Beer B; Denner J; Brown CR; Norley S; zur Megede J; Coulibaly C; Plesker R; Holzammer S; Baier M; Hirsch VM; Kurth R
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jul; 18(3):210-20. PubMed ID: 9665497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infected macaques that controlled replication of SIVmac or nonpathogenic SHIV developed sterilizing resistance against pathogenic SHIV(KU-1).
    Stephens EB; Joag SV; Atkinson B; Sahni M; Li Z; Foresman L; Adany I; Narayan O
    Virology; 1997 Aug; 234(2):328-39. PubMed ID: 9268165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine effect using a live attenuated nef-deficient simian immunodeficiency virus of African green monkeys in the absence of detectable vaccine virus replication in vivo.
    Beer B; Baier M; zur Megede J; Norley S; Kurth R
    Proc Natl Acad Sci U S A; 1997 Apr; 94(8):4062-7. PubMed ID: 9108105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.